Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Agios Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 225
- +17 vs. Q3 2024
- Shares held
- 59.8M
- +1.74M (+3.0%) vs. Q3 2024
- Total value
- $1.97B
- −$616.0M (−23.8%) vs. Q3 2024
- New holders
- 41
- 85 more added
- Sold out
- 24
- 71 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 595,480 | $19.6M | 0.00% | +5,372+0.9% | Added |
| Caligan Partners LP | 626,280 | $20.6M | 5.21% | +46,563+8.0% | Added |
| Polar Capital Holdings Plc | 627,036 | $20.6M | 0.12% | −375,000−37.4% | Reduced |
| Marshall Wace, LLP | 631,628 | $20.8M | 0.03% | −631,657−50.0% | Reduced |
| GW&K Investment Management, LLC | 683,463 | $22.5M | 0.19% | +52,517+8.3% | Added |
| ArrowMark Colorado Holdings LLC | 917,420 | $30.1M | 0.41% | +34,689+3.9% | Added |
| Deutsche Bank AG | 935,252 | $30.7M | 0.01% | +265,637+39.7% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 942,189 | $31.0M | 0.08% | +35,145+3.9% | Added |
| Fisher Asset Management, LLC | 960,661 | $31.6M | 0.01% | +105,333+12.3% | Added |
| JPMorgan Chase & Co | 1,015,360 | $33.4M | 0.00% | −697,630−40.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,069,754 | $35.2M | 1.46% | +25,600+2.5% | Added |
| BVF Inc | 1,073,755 | $35.3M | 1.20% | −116,352−9.8% | Reduced |
| Dimensional Fund Advisors LP | 1,329,065 | $43.7M | 0.01% | −233,118−14.9% | Reduced |
| Geode Capital Management, LLC | 1,349,651 | $44.4M | 0.00% | −7,880−0.6% | Reduced |
| Citadel Advisors LLC | 1,433,676 | $47.1M | 0.04% | +1,421,940+12,116.1% | Added |
| Jefferies Financial Group Inc. | 1,500,000 | $49.3M | 0.55% | +1,500,000 | New |
| Macquarie Group Ltd | 1,684,993 | $55.4M | 0.07% | −5,808−0.3% | Reduced |
| Erste Asset Management GmbH | 2,009,900 | $66.4M | 0.81% | −175,000−8.0% | Reduced |
| State Street Corp | 2,152,277 | $70.7M | 0.00% | −179,156−7.7% | Reduced |
| Armistice Capital, LLC | 2,264,304 | $74.4M | 1.73% | +57,234+2.6% | Added |
| Price T Rowe Associates Inc | 2,423,537 | $79.6M | 0.01% | −408,975−14.4% | Reduced |
| Bellevue Group AG | 3,515,150 | $115.5M | 2.22% | −220,765−5.9% | Reduced |
| BlackRock, Inc. | 5,016,260 | $164.8M | 0.00% | −5,507−0.1% | Reduced |
| Vanguard Group Inc | 5,631,321 | $185.0M | 0.00% | +85,339+1.5% | Added |
| Farallon Capital Management, L.L.C. | 5,674,466 | $186.5M | 0.98% | +13,600+0.2% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −760,000−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −285,099−100.0% | Sold out |
| Summit Partners Public Asset Management, LLC | 0 | $0 | 0.00% | −101,730−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −74,273−100.0% | Sold out |
| Sector Gamma AS | 0 | $0 | 0.00% | −67,908−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −66,200−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −43,708−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −21,300−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,864−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −9,827−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −8,544−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −7,409−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −6,069−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −5,751−100.0% | Sold out |
| Northcape Wealth Management, LLC | 0 | $0 | 0.00% | −5,670−100.0% | Sold out |
| North Star Asset Management Inc | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −425−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −345−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −166−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| CarsonAllaria Wealth Management, Ltd. | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |